Biotechnology company developing topical treatments for chronic skin diseases using genetically engineered skin probiotics
Biotechnology company developing topical treatments for chronic skin diseases using genetically engineered skin probiotics. Its engineered bacteria are applied in a moisturizer and continuously produce therapeutic proteins in the skin to address disease-related protein imbalances. Pipeline targets include Netherton syndrome, atopic dermatitis/eczema, psoriasis, acne, and rosacea.